Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Measles Vaccine”

236 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 236 results

Not applicableLooking for participantsNCT06686342
What this trial is testing

PDO Based Drug Sensitive Test in R/M HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaPatient Derived OrganoidDrug Sensitive Test in Vitro
Huashan Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06323239
What this trial is testing

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 148
Post-approval studies (Phase 4)Looking for participantsNCT04899765
What this trial is testing

Measles and BCG Vaccines for Mother and Child

Who this might be right for
Vaccine Preventable DiseaseMeaslesMother-Infant Interaction+1 more
Bandim Health Project 2,400
Not applicableStudy completedNCT04646239
What this trial is testing

Biomarkers of Trained Immunity Following MMR Vaccination

Who this might be right for
Covid19
Washington University School of Medicine 96
Post-approval studies (Phase 4)Study completedNCT05161845
What this trial is testing

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

Who this might be right for
ImmunotoxicityVaccine
Shanghai Institute Of Biological Products 1,068
Not applicableUnknownNCT00645996
What this trial is testing

The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants

Who this might be right for
ImmunityMeaslesMumps+1 more
Assaf-Harofeh Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00450814
What this trial is testing

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Mayo Clinic 48
Post-approval studies (Phase 4)Study completedNCT01668745
What this trial is testing

Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso.

Who this might be right for
Measles Vaccine
Bandim Health Project 4,559
Testing effectiveness (Phase 2)Study completedNCT05156970
What this trial is testing

Camrelizumab in Combination With Chemotherapy or Apatinib Mesylate as First-Line Treatment for R/M HNSCC

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 81
Post-approval studies (Phase 4)UnknownNCT05952505
What this trial is testing

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines

Who this might be right for
SARS-CoV-2 InfectionVaricellaMeasles+2 more
Shanghai Municipal Center for Disease Control and Prevention 540
Not applicableUnknownNCT05154097
What this trial is testing

Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)

Who this might be right for
Measles Vaccine
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 190
Early research (Phase 1)UnknownNCT03799744
What this trial is testing

Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell of Head and NeckMetastasis+1 more
Institut Català d'Oncologia 20
Testing effectiveness (Phase 2)Study completedNCT04398706
What this trial is testing

Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Who this might be right for
Pneumococcal ImmunisationDiphtheria ImmunisationTetanus Immunisation+8 more
Sanofi Pasteur, a Sanofi Company 852
Testing effectiveness (Phase 2)Looking for participantsNCT04857164
What this trial is testing

Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yuankai Shi 150
Early research (Phase 1)UnknownNCT04213404
What this trial is testing

Ribociclib and Spartalizumab in R/M HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
National Taiwan University Hospital 13
Testing effectiveness (Phase 2)Study completedNCT03807843
What this trial is testing

Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006)

Who this might be right for
Chikungunya Virus Infection
Themis Bioscience GmbH 41
Not applicableStudy completedNCT02710045
What this trial is testing

The Interaction Between Measles and DTP Vaccination

Who this might be right for
Non-target Heterologous Effects of VaccinesVaccine Interactions
Medical Research Council Unit, The Gambia 302
Not applicableStudy completedNCT00240916
What this trial is testing

Ontogeny of Measles Immunity in Infants

Who this might be right for
Measles
Stanford University 750
Not applicableLooking for participantsNCT05923970
What this trial is testing

Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?

Who this might be right for
Vaccination FailureVaccine Response Impaired
University of Alberta 200
Testing effectiveness (Phase 2)Study completedNCT03284424
What this trial is testing

Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)

Who this might be right for
Squamous Cell Carcinoma
Merck Sharp & Dohme LLC 159
Next Page